Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

12.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.3K
Blood Types02:20

Blood Types

20.4K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
20.4K
Introduction to Hemostasis01:05

Introduction to Hemostasis

11.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.4K
Sex-linked Disorders01:43

Sex-linked Disorders

105.1K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
105.1K
Rh Blood Group01:19

Rh Blood Group

2.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Delphi Consensus by Hematologists on the Burden of Treatment on Patients with Severe Hemophilia in Mexico.

Journal of blood medicine·2026
Same author

Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study.

EJHaem·2026
Same author

Dysregulation of the FVIII-VWF Axis in Early-Onset Ischemic Stroke.

Seminars in thrombosis and hemostasis·2026
Same author

Factor XII Deficiency and Thrombosis Risk: A Systematic Review and Meta-Analysis.

Archives of medical research·2026
Same author

Outpatient Delivery of Step-Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma.

European journal of haematology·2026
Same author

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound.

Gaceta medica de Mexico·2026
Same journal

Prevalence of suspected non-alcoholic fatty liver disease in pediatric patients.

Gaceta medica de Mexico·2026
Same journal

Healthcare-associated pneumonia in patients with Guillain-Barré syndrome: risk factors and main isolated microorganisms.

Gaceta medica de Mexico·2026
Same journal

Baseline brain magnetic resonance imaging findings as predictors of dementia progression: insights from a Mexican memory clinic.

Gaceta medica de Mexico·2026
Same journal

Alternative dispute resolution mechanisms in the doctor-patient relationship.

Gaceta medica de Mexico·2026
Same journal

The rare in the common: unsuspected Fabry disease in a large family with common diseases.

Gaceta medica de Mexico·2026
See all related articles

Related Experiment Video

Updated: Nov 10, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.8K

Consensus on hemophilia in Mexico.

José L López-Arroyo1, Juan M Pérez-Zúñiga2, Laura E Merino-Pasaye2

  • 1Hematology department, Hospital General "B" del ISSSTE, Ciudad Juárez, Chih. Mexico.

Gaceta Medica De Mexico
|April 5, 2021
PubMed
Summary
This summary is machine-generated.

Hemophilia, a genetic bleeding disorder, results from deficiencies in coagulation factors VIII or IX. This review covers genetics, manifestations, diagnosis, and evolving treatments, including factor-based and factor-free therapies.

Keywords:
Acquired Hemophilia AConsensoConsensusHemofiliaHemofilia A adquiridaHemophiliaReviewRevisión

More Related Videos

Raising the Mexican Tetra Astyanax mexicanus for Analysis of Post-larval Phenotypes and Whole-mount Immunohistochemistry
06:42

Raising the Mexican Tetra Astyanax mexicanus for Analysis of Post-larval Phenotypes and Whole-mount Immunohistochemistry

Published on: December 28, 2018

9.3K
Gamete Collection and In Vitro Fertilization of Astyanax mexicanus
10:52

Gamete Collection and In Vitro Fertilization of Astyanax mexicanus

Published on: May 25, 2019

9.7K

Related Experiment Videos

Last Updated: Nov 10, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.8K
Raising the Mexican Tetra Astyanax mexicanus for Analysis of Post-larval Phenotypes and Whole-mount Immunohistochemistry
06:42

Raising the Mexican Tetra Astyanax mexicanus for Analysis of Post-larval Phenotypes and Whole-mount Immunohistochemistry

Published on: December 28, 2018

9.3K
Gamete Collection and In Vitro Fertilization of Astyanax mexicanus
10:52

Gamete Collection and In Vitro Fertilization of Astyanax mexicanus

Published on: May 25, 2019

9.7K

Area of Science:

  • Genetics and Molecular Biology
  • Hematology
  • Medical Science

Background:

  • Hemophilia is a sex-linked inherited hemorrhagic disorder caused by deficiencies in coagulation factor VIII (hemophilia A) or factor IX (hemophilia B).
  • Genetic sequencing has identified key mutations correlating with disease severity.
  • Hemorrhagic manifestations primarily affect the musculoskeletal system, particularly large joints.

Framework:

  • This review synthesizes current knowledge on hemophilia's genetic aspects, inheritance patterns, and carrier status in women.
  • It details the pathophysiology, classification, and diagnostic studies for suspected hemophilia.
  • The document establishes a consensus on management strategies.

Implementation:

  • Treatment involves factor replacement therapy (infusion of deficient factors).
  • Innovative factor-free therapies are emerging as alternative treatment options.
  • Management addresses complications like inhibitor development, transfusion-transmitted infections, and hemophilic arthropathy.

Implications:

  • Understanding genetic underpinnings guides diagnosis and personalized treatment approaches.
  • Advances in therapy offer improved outcomes and quality of life for patients.
  • This consensus provides a framework for managing hemophilia and its complications, including acquired hemophilia.